| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2006 | EP1684720A2 Introducing aerosol into a ventilator circuit |
| 08/02/2006 | EP1684717A2 Pharmaceutical aerosol compositions |
| 08/02/2006 | EP1684715A2 Compositions comprising cyclohexylamines and aminoadamantanes |
| 08/02/2006 | EP1684714A2 Process for producing injectable gabapentin compositions |
| 08/02/2006 | EP1684713A1 Controlled release of topirimate in liquid dosage forms |
| 08/02/2006 | EP1684712A2 Combination drug therapy to treat obesity |
| 08/02/2006 | EP1684711A2 Composition |
| 08/02/2006 | EP1684706A2 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter |
| 08/02/2006 | EP1684704A2 Compositions and methods for increasing hdl and hdl-2b levels |
| 08/02/2006 | EP1684703A2 Methods and compositions for treating mcp-1 related pathologies |
| 08/02/2006 | EP1684702A2 Use of 2-thia-dibenzo(e,h) azulenes for the treatment and prevention of central nervous system diseaes and disorders |
| 08/02/2006 | EP1684701A2 Compositions for achieving benefits in skin using key cellular metabolic intermediates |
| 08/02/2006 | EP1684694A2 Akt protein kinase inhibitors |
| 08/02/2006 | EP1684690A2 Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 08/02/2006 | EP1684689A2 Extended release venlafaxine formulation |
| 08/02/2006 | EP1684593A2 Method of decreasing fat deposits and body weight in mammals and birds |
| 08/02/2006 | EP1605947B1 Use of pteridine derivatives for the treatment of increased intracranial pressure |
| 08/02/2006 | EP1594566A4 Implantable method to regulate blood pressure by means of coded nerve signals |
| 08/02/2006 | EP1578416B1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles |
| 08/02/2006 | EP1565473B1 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors |
| 08/02/2006 | EP1562611B1 Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone) |
| 08/02/2006 | EP1556045B1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 08/02/2006 | EP1532147B1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 08/02/2006 | EP1529043B1 Process for the preparation of 2-methyl piperazine derivatives. |
| 08/02/2006 | EP1507762B1 Pesticidal pyridinecarboxamide derivatives |
| 08/02/2006 | EP1505965B1 Use of the metabolite of valsartan to inhibit platelet aggregation |
| 08/02/2006 | EP1496882B1 Tolterodine salts |
| 08/02/2006 | EP1492821B1 Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 08/02/2006 | EP1485389B1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 08/02/2006 | EP1478380B1 Use of tyrosine kinase inhibitors for treating cns disorders |
| 08/02/2006 | EP1435971B1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 08/02/2006 | EP1435941B1 Wortmannin analogs and methods of using same |
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1341565B1 Drug delivery compositions and coated medical devices |
| 08/02/2006 | EP1333887B1 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/02/2006 | EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 08/02/2006 | EP1328280B1 Composition for the treatment of dysglucaemia and method for the production of said composition |
| 08/02/2006 | EP1326617B1 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma |
| 08/02/2006 | EP1325003B1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino 4,5-b|quinoline-1,10-dione and the use thereof for the treatment of pain |
| 08/02/2006 | EP1305022A4 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures |
| 08/02/2006 | EP1296656B1 Method for preparing a composition |
| 08/02/2006 | EP1276485B1 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1274421B1 Use of MEK-inhibitors for producing a medicament to treat negativstrang-RNA-viruses infections |
| 08/02/2006 | EP1272196B1 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1263418B1 Method of preparing cartilage enhancing food supplements |
| 08/02/2006 | EP1249235B1 Remedies for hepatitis containing alanine and glycine |
| 08/02/2006 | EP1246616B1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 08/02/2006 | EP1239791B1 Dental prosthesis with means for the release of active substances |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 08/02/2006 | EP1163274B1 Process for cross-linking hyaluronic acid to polymers |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1107974B1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
| 08/02/2006 | EP1076057B1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 08/02/2006 | EP1073637B1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP1006793B1 Anti-arrhythmic composition and methods of treatment |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | EP0939621B1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 08/02/2006 | EP0923380A4 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 08/02/2006 | EP0862428B1 Ginkgolides for inhibition of membrane expression |
| 08/02/2006 | CN1813000A Synthetic antibody phage libraries |
| 08/02/2006 | CN1812994A Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
| 08/02/2006 | CN1812992A HIV integrase inhibitors |
| 08/02/2006 | CN1812987A Substituted diketopiperazines and their use as oxytocyn antagonists |
| 08/02/2006 | CN1812986A Furazanobenzimidazoles |
| 08/02/2006 | CN1812985A Mch antagonists for the treatment of obesity |
| 08/02/2006 | CN1812984A Benzofuranyl-and benzothienyl-piperazinyl quinolines as 5-serotonin reuptake inhibitors |
| 08/02/2006 | CN1812983A Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 08/02/2006 | CN1812982A Benzodiazepine cgrp receptor antagonists |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812980A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 08/02/2006 | CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812972A Caspase inhibitors and uses thereof |
| 08/02/2006 | CN1812968A Polymorphic form a of 4-{6-acetyl-3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy}-2-propylphenoxy}butyric acid |
| 08/02/2006 | CN1812963A N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/02/2006 | CN1812961A Propionamide derivatives useful as androgen receptor modulators |
| 08/02/2006 | CN1812960A 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812802A Formulations for the treatment of arhritis conditions |
| 08/02/2006 | CN1812799A Pharmaceutical composition for improved administration of HIV gp41-derived peptides,And its use in therapy |
| 08/02/2006 | CN1812798A Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |